tirzepatide cardiovascular outcomes trial results august 2025 Comparative efficacy of and glucagon-like peptide-1 receptor Ocular Outcomes with Tirzepatide versus

Both have shown excellent results in clinical trials, but how do you know which one is right for you

Always leave the needle cap on until youre ready to use it

Some people burp from the very first dose

Mechanism difference Semaglutide (GLP-1 agonist): appetite regulation, satiety, improved glycemic control (New England Journal of Medicine) Tirzepatide (GLP-1/GIP agonist): broader incretin effects, robust appetite/weight effects (New England Journal of Medicine) AOD-9604: targeted fat-metabolism signaling

see NHS guidance and Xenical/Alli SmPCs), and injectable GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda)

Semaglutide and orlistat are suitable for people with specific health needs related to obesity or overweight